Current and emerging treatment options for myopic choroidal neovascularization

Choroidal neovascularization (CNV) is the main cause of visual impairment in highly myopic patients younger than 50 years of age. There are different treatments for myopic CNV (mCNV), with 5- to 10-year outcomes currently. Chorioretinal atrophy is still the most important determinant factor for visu...

Descripción completa

Detalles Bibliográficos
Autores principales: El Matri, Leila, Chebil, Ahmed, Kort, Fedra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4422283/
https://www.ncbi.nlm.nih.gov/pubmed/25987831
http://dx.doi.org/10.2147/OPTH.S49437
_version_ 1782370031738290176
author El Matri, Leila
Chebil, Ahmed
Kort, Fedra
author_facet El Matri, Leila
Chebil, Ahmed
Kort, Fedra
author_sort El Matri, Leila
collection PubMed
description Choroidal neovascularization (CNV) is the main cause of visual impairment in highly myopic patients younger than 50 years of age. There are different treatments for myopic CNV (mCNV), with 5- to 10-year outcomes currently. Chorioretinal atrophy is still the most important determinant factor for visual outcome. The purpose of this study is to provide an overview of the current treatments for mCNV, including laser, surgical management, verteporfin photodynamic therapy, and mainly anti-vascular endothelial growth factor therapy. Emerging treatment options are also discussed.
format Online
Article
Text
id pubmed-4422283
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-44222832015-05-18 Current and emerging treatment options for myopic choroidal neovascularization El Matri, Leila Chebil, Ahmed Kort, Fedra Clin Ophthalmol Review Choroidal neovascularization (CNV) is the main cause of visual impairment in highly myopic patients younger than 50 years of age. There are different treatments for myopic CNV (mCNV), with 5- to 10-year outcomes currently. Chorioretinal atrophy is still the most important determinant factor for visual outcome. The purpose of this study is to provide an overview of the current treatments for mCNV, including laser, surgical management, verteporfin photodynamic therapy, and mainly anti-vascular endothelial growth factor therapy. Emerging treatment options are also discussed. Dove Medical Press 2015-04-24 /pmc/articles/PMC4422283/ /pubmed/25987831 http://dx.doi.org/10.2147/OPTH.S49437 Text en © 2015 El Matri et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Review
El Matri, Leila
Chebil, Ahmed
Kort, Fedra
Current and emerging treatment options for myopic choroidal neovascularization
title Current and emerging treatment options for myopic choroidal neovascularization
title_full Current and emerging treatment options for myopic choroidal neovascularization
title_fullStr Current and emerging treatment options for myopic choroidal neovascularization
title_full_unstemmed Current and emerging treatment options for myopic choroidal neovascularization
title_short Current and emerging treatment options for myopic choroidal neovascularization
title_sort current and emerging treatment options for myopic choroidal neovascularization
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4422283/
https://www.ncbi.nlm.nih.gov/pubmed/25987831
http://dx.doi.org/10.2147/OPTH.S49437
work_keys_str_mv AT elmatrileila currentandemergingtreatmentoptionsformyopicchoroidalneovascularization
AT chebilahmed currentandemergingtreatmentoptionsformyopicchoroidalneovascularization
AT kortfedra currentandemergingtreatmentoptionsformyopicchoroidalneovascularization

Ejemplares similares